SLANG Worldwide Announces Fourth Quarter and Year End 2022 Financial Results
SLANG Worldwide Announces Fourth Quarter and Year End 2022 Financial Results
Generated positive operational cash flow in Q4 FY2022 and Q1 FY2023, achieving two consecutive quarters of positive operational cash flow1,2.
Adjusted gross profit1 of $17.62 million (46% adjusted gross margin1) in FY 2022, compared with $14.47 million adjusted gross profit (38% adjusted gross margin) in FY 2021, representing a 22% increase year-over-year.
在2022財年第四季度和2023財年第一季度產生了正運營現金流，實現了連續兩個季度的運營現金流正增長1，2.。
調整後的毛利11762萬美元(調整後的毛利率為46%12022財年，與2021財年的1447萬美元調整後毛利(38%調整後毛利率)相比，同比增長22%。
Cash and cash equivalents of $11.9 million at December 31, 2022, and a clean balance sheet with well-structured debt requiring non-material payments.
截至2022年12月31日的現金和現金等價物為1190萬美元，以及乾淨的資產負債表，結構良好的債務需要非物質付款。
In September 2022, obtained a recreational retail license in Vermont and opened the state's first recreational cannabis store in Burlington, Vermont. Subsequently, SLANG's sales in the state exceeded $5.38 million in Q4, significantly outpacing forecasted growth for the year, driving full year Vermont sales to $10.96 million.
2022年9月，他在佛蒙特州獲得了娛樂零售許可證，並在佛蒙特州伯靈頓開設了該州第一家娛樂大麻商店。隨後，俚語在該州的銷售額在第四季度超過了538萬美元，大大超過了全年的預期增長，推動佛蒙特州全年銷售額達到1096萬美元。
THC free wholesale distribution introduced new higher margin sales in a key growth channel.
免費批發分銷在一個關鍵的增長渠道引入了新的更高利潤率的銷售。
Toronto, Ontario--(Newsfile Corp. - April 27, 2023) - SLANG Worldwide Inc. (CNSX: SLNG) (OTCQB: SLGWF) ("SLANG" or the "Company"), a leading global cannabis consumer packaged goods (CPG) company with a diversified portfolio of popular brands, today released financial results for the three and twelve months ended December 31, 2022. All figures in this press release are stated in Canadian dollars unless otherwise noted.
安大略省多倫多-(Newsfile Corp.-2023年4月27日)-俚語全球公司。(CNSX：SLNG)(OTCQB：SLGWF)(“俚語“或”公司“)，全球領先的大麻消費包裝產品(CPG)公司，擁有多元化的流行品牌組合，今天發佈了截至2022年12月31日的三個月和十二個月的財務業績。除非另有說明，本新聞稿中的所有數位均以加元表示。
Key Financial Highlights:
主要財務亮點：
- Generated positive operational cash flow in Q4 FY2022 and again subsequent to the end of the year in Q1 FY2023, achieving two consecutive quarters of positive operational cash flow1,2.
- Revenue from continuing operations for FY 2022 was $38.19 million, compared with $37.78 million in FY 2021, representing a 1% increase year-over-year. The primary driver of the increase was the recognition of a full year of revenue from High Fidelity, Inc. ("HiFi") in Vermont, offset by a reduction in revenue resulting from shifting Oregon from a Core Market to an Emerging Market which was completed in Q4 2021, and a reduction in Emerging Market sales.
- Adjusted gross profit1 of $17.62 million (46% adjusted gross margin1) in FY 2022, compared with $14.47 million adjusted gross profit (38% adjusted gross margin) in FY 2021, representing a 22% increase year-over-year.
- Adjusted EBITDA1 of ($3.65 million) in FY 2022, compared with ($5.63 million) in FY 2021. The improvement in Adjusted EBITDA is primarily attributable to a $3.16 million increase in Adjusted gross profit, offset by an increase in operating expenditures related to HiFi, which is not presented in the comparative period before August 11, 2021.
- EBITDA1 of ($8.71 million) in FY 2022, compared with ($17.49 million) in FY 2021. The improvement in EBITDA is primarily attributable to a decrease in operating expenditures (excluding depreciation and amortization) of $7.41 million and an increase in gross profit of $1.32 million.
- $11.9 million in cash and restricted cash on December 31, 2022, compared to $20.83 million on December 31, 2021.
- 在2022財年第四季度產生了正運營現金流，在2023財年第一季度又產生了運營現金流，實現了連續兩個季度的運營現金流正增長1，2.。
- 2022財年來自持續運營的收入為3819萬美元，而2021財年為3778萬美元，同比增長1%。增長的主要驅動因素是確認了佛蒙特州高保真公司(High Fidelity，Inc.)全年的收入，但被2021年第四季度完成的俄勒岡州從核心市場轉移到新興市場導致的收入減少以及新興市場銷售額的減少所抵消。
- 調整後的毛利11762萬美元(調整後的毛利率為46%12022財年，與2021財年的1447萬美元調整後毛利(38%調整後毛利率)相比，同比增長22%。
- 調整後的EBITDA12022財年為365萬美元，而2021財年為563萬美元。調整後EBITDA的改善主要是由於調整後毛利增加了316萬美元，但被與高保真相關的運營支出增加所抵消，這一增長沒有在2021年8月11日之前的比較期間公佈。
- EBITDA12022財年(871萬美元)，而2021財年(1749萬美元)。EBITDA的改善主要是由於營業支出(不包括折舊和攤銷)減少741萬美元，毛利潤增加132萬美元。
- 2022年12月31日的現金和限制性現金為1190萬美元，而2021年12月31日為2083萬美元。
John Moynan, Chief Executive Officer of SLANG, commented, "2022 was a transformational year for SLANG, and the Company is demonstrating exceptional financial performance relative to its peer group. In Q4 FY2022, we achieved positive operational cash flow for the first time in the Company's history, which we also generated subsequent to year end in Q1 FY2023, meaning we have now produced two consecutive quarters of positive operational cashflow. We continue to consolidate our supply chain and streamline our operations to drive financial results across our Core and Emerging markets. In the month of October 2022, we achieved cash flow positivity for the first time in the Company's history. We demonstrated year-over-year adjusted gross margin growth for each quarter of 2022, and we believe this trend will continue as we drive revenue growth in our most profitable channels."
俚語公司首席執行官約翰·莫伊南評論說：“2022年是俚語公司轉型的一年，與其同行相比，公司表現出了非凡的財務業績。在2022財年第四季度，我們在公司歷史上首次實現了運營現金流為正，這也是我們在2023財年第一季度結束後產生的運營現金流，這意味著我們現在已經連續兩個季度實現運營現金流為正。我們繼續鞏固我們的供應鏈和精簡我們的運營，以推動我們的核心市場和新興市場的財務業績。2022年10月，我們在公司歷史上首次實現現金流為正。我們展示了2022年每個季度調整後毛利率的同比增長，我們相信，隨著我們推動最有利可圖的渠道的收入增長，這一趨勢將繼續下去。“
Mr. Moynan added, "We continued to demonstrate success in our Core markets of Vermont and Colorado, with several key milestones achieved over the year. Our products maintain leading status in the country's most competitive cannabis markets, with a portfolio of best-in-class brands - in particular, O.pen, which remains today's top selling vape cartridge product in Colorado, a position it has maintained for the last 8 years3. O.pen sales remain strong, and this year the brand has outpaced the competition by a wide margin despite challenging market conditions. In 2023, SLANG is focused on expanding our market share through product sales channels, such as THC-free, to diversify our profitable revenue streams. We will further build upon our successful partnership model to enter new emerging markets in a capital-efficient manner, strategically positioning our brands at the forefront of the industry and SLANG for continued growth."
莫伊南先生補充說：“我們繼續在佛蒙特州和科羅拉多州的核心市場取得成功，在過去一年中取得了幾個關鍵的里程碑。我們的產品在全國競爭最激烈的大麻市場保持領先地位，擁有一系列同類中最好的品牌-特別是O.Pen，它仍然是科羅拉多州今天最暢銷的蒸汽盒產品，過去8年來一直保持這一地位3.。O.Pen的銷售依然強勁，今年，儘管市場環境充滿挑戰，但該品牌的表現遠遠超過了競爭對手。2023年，俚語將專注於通過產品銷售渠道(如無THC)擴大我們的市場份額，以使我們的盈利收入來源多樣化。我們將進一步建立我們成功的合作模式，以資本高效的方式進入新的新興市場，從戰略上將我們的品牌定位在行業的前沿，並用俚語來表示持續增長。“
Operational Highlights and Growth Drivers:
運營亮點和增長動力：
- On September 28, 2022, Vermont regulators issued an integrated marijuana license to the Company allowing the Company to open its CERES Collaborative dispensary on October 1, 2022, Vermont's first recreational cannabis store.
- O.pen has been ranked the #1 Vape Brand in Colorado each year since 2015, and SLANG launched the 10 Years of O.pen program in October, with special incentives driving record sales for O.pen in Colorado with a 229% increase in sales from August to September. This success prompted a new strategic approach in 2023, focused on structured, brand-driven promotions during key sales periods throughout the year. In the first two O.pen promotions of Q1 2023, the Company has seen its top 5 highest volume accounts deliver a 30-66% year-over-year sales lift.
- New vertically integrated operations in Vermont generated $11 million in revenue in FY 2022, significantly outpacing the Company's forecasts for the State.
- Successfully launched Alchemy Naturals Edibles in Colorado in July and e-commerce in September with an 8% growth in dollar sales from July to September.
- Expanded into new markets, launching operations in Michigan and Maryland in May 2022, and in West Virginia subsequent to year end in April 2023 through strategic partnerships with leading, high-quality premium cannabis brands and operators in those states.
- 2022年9月28日，佛蒙特州監管機構向該公司發放了綜合大麻許可證，允許該公司於2022年10月1日開設其Ceres Collaborative藥房，這是佛蒙特州第一家娛樂性大麻商店。
- 自2015年以來，O.Pen每年都被評為科羅拉多州排名第一的Vape品牌，slang在10月份推出了O.Pen的10年計劃，特別的激勵措施推動了O.Pen在科羅拉多州創紀錄的銷售，8-9月銷售額增長了22.9%。這一成功促使2023年採取了新的戰略方法，重點是在全年關鍵銷售期進行有組織的、以品牌為導向的促銷活動。在2023年第一季度的前兩次O.Pen促銷活動中，該公司的前5個銷量最高的客戶的銷售額同比增長了30%-66%。
- 佛蒙特州新的垂直整合業務在2022財年創造了1100萬美元的收入，大大超過了該公司對該州的預測。
- 7月份在科羅拉多州成功推出了煉金術自然食品，9月份成功推出了電子商務，7-9月美元銷售額增長了8%。
- 該公司通過與密歇根州和馬利蘭州領先的優質大麻品牌和運營商建立戰略合作夥伴關係，於2022年5月在密歇根州和馬利蘭州開展業務，並於2023年4月年底在西弗吉尼亞州開展業務。
Financial Year 2022 Corporate Updates
2022財年公司最新情況
- In October, Mr. John Moynan was promoted to Chief Executive Officer of the Company and Ms. Ruth Chun, an independent director of the Company, was appointed Chair of the Board.
- Announced newly formulated M&A and Investment Committee chaired by independent board member Kevin Albert.
- 於十月，莫伊南先生晉升為本公司行政總裁，而本公司獨立董事董事純女士則獲委任為董事會主席。
- 宣佈由獨立董事會成員凱文·阿爾伯特擔任主席的新組建的並購和投資委員會。
Fourth Quarter 2022 Financial Highlights
2022年第四季度財務亮點
- Revenue from continuing operations for the three months ended December 31, 2022, was $11.78 million, compared with $8.84 million in the three months ended December 31, 2021, representing a 33% increase year-over-year. The primary drivers of the increase were an increase in our Core Market sales of $0.46 million in Colorado and $3.37 million in Vermont, offset by a decrease in our Emerging Market sales of $0.86 million.
- Gross profit of $4.70 million (40% gross margin) in Q4 2022, compared with $4.10 million (46% gross margin) in Q4 2021, representing a 6% decrease year-over-year. Gross profit before fair value of biological assets was $5.70 million (48% gross margin) in Q4 2022, compared with $3.34 million (38% gross margin) in Q4 2021, representing a 71% increase year-over-year.
- Adjusted EBITDA of ($.056 million) in Q4 2022, compared with ($2.90 million) in Q4 2021. The improvement in Adjusted EBITDA is primarily attributable to a $2.36 million increase in gross profit before fair value adjustments on biological assets, and decreases in consulting and subcontractor operating expenses.
- EBITDA of ($1.82 million) in Q4 2022, compared with ($4.87 million) in Q4 2021. The improvement in EBITDA is primarily attributable to an increase in gross profit of $0.60 million and decreases in operating expenditures consisting mainly of consulting and subcontractors, share based payments, and expected credit losses.
- 截至2022年12月31日的三個月，持續運營收入為1178萬美元，而截至2021年12月31日的三個月為884萬美元，同比增長33%。增長的主要驅動因素是我們在科羅拉多州的核心市場銷售額增加了46萬美元，在佛蒙特州增加了337萬美元，但被我們新興市場銷售額減少的86萬美元所抵消。
- 2022年第四季度毛利為470萬美元(毛利率為40%)，而2021年第四季度為410萬美元(毛利率46%)，同比下降6%。2022年第四季度生物資產的公允價值前毛利為570萬美元(毛利率為48%)，而2021年第四季度為334萬美元(毛利率38%)，同比增長71%。
- 2022年第四季度調整後的EBITDA為(05.6萬美元)，而2021年第四季度為(290萬美元)。調整後EBITDA的改善主要歸因於生物資產公允價值調整前毛利增加236萬美元，以及諮詢和分包商運營費用減少。
- 2022年第四季度EBITDA為182萬美元，而2021年第四季度為487萬美元。EBITDA的改善主要是由於毛利潤增加了60萬美元，以及主要由諮詢和分包商、基於股份的付款和預期的信貸損失組成的運營支出減少。
Full Year 2022 Financial Review
2022年全年財務回顧
The consolidated financial statements were prepared in accordance with IFRS. The following is a selected presentation of the Income Statement for the three and twelve months ended December 31, 2022.
綜合財務報表是根據國際財務報告準則編制的。以下是截至2022年12月31日的三個月和十二個月的損益表的精選列報。
| 3 months ended |
3 months ended |
12 months ended |
12 months ended |
| ||||||||
| 31-Dec-22 | 31-Dec-21 | 31-Dec-22 | 31-Dec-21 | |||||||||
| (In thousands except per share data and percentages) | CDN | CDN | CDN | CDN | ||||||||
| Net Operating Revenue From Continuing Operations | $ | 11,777 | $ | 8,838 | $ | 38,189 | $ | 37,777 | ||||
| Cost of Goods Sold | 6,077 | 5,501 | 20,566 | 23,311 | ||||||||
| Gross Profit Before Fair Value Adjustment of Biological Assets | 5,700 | 3,337 | 17,623 | 14,466 | ||||||||
| Realized fair value amounts included in inventory sold | (1,298 | ) | (501 | ) | (2,976 | ) | (886 | ) | ||||
| Unrealized gain on fair value of biological assets | 293 | 1,264 | 1,799 | 1,547 | ||||||||
| Gross Profit | 4,695 | 4,100 | 16,446 | 15,127 | ||||||||
| Gross Profit Margin | 40% | 46% | 43% | 40% | ||||||||
| Operating expenses | 8,167 | 11,053 | 31,332 | 40,463 | ||||||||
| Operating Loss | (3,472 | ) | (6,953 | ) | (14,886 | ) | (25,336 | ) | ||||
| Other items (Impairment, FV adjustment, FX, gains/losses, taxes, etc.) | 13,483 | 30,149 | 14,767 | 31,197 | ||||||||
| Total Comprehensive Loss | (16,955 | ) | (37,102 | ) | (29,653 | ) | (56,533 | ) | ||||
| Earnings Per Share From Continuing Operations | ||||||||||||
| Basic | $ | (0.15 | ) | $ | (0.39 | ) | $ | (0.29 | ) | $ | (0.60 | ) |
| Diluted | $ | (0.15 | ) | $ | (0.39 | ) | $ | (0.29 | ) | $ | (0.60 | ) |
| 3個月 告一段落 |
3個月 告一段落 |
12個月 告一段落 |
12個月 告一段落 |
| ||||||||
| 12月31日至22日 | 12月31日-12月21日 | 12月31日至22日 | 12月31日-12月21日 | |||||||||
| (除每股數據和百分比外，以千為單位) | CDN | CDN | CDN | CDN | ||||||||
| 持續經營的淨營業收入 | $ | 11,777 | $ | 8838 | $ | 38,189 | $ | 37,777 | ||||
| 銷貨成本 | 6,077 | 5,501 | 20,566 | 23,311 | ||||||||
| 生物資產公允價值調整前毛利 | 5700 | 3337 | 17,623 | 14,466 | ||||||||
| 已實現公允價值包含在已銷售存貨中的金額 | (1298 | ) | (501) | ) | (2,976 | ) | (886) | ) | ||||
| 生物資產公允價值未實現收益 | 293 | 1264 | 1,799 | 1,547 | ||||||||
| 毛利 | 4695 | 4100 | 16,446 | 15,127 | ||||||||
| 毛利率 | 40% | 百分之四十六 | 43% | 40% | ||||||||
| 運營費用 | 8,167 | 11,053 | 31,332 | 40,463 | ||||||||
| 營業虧損 | (3,472 | ) | (6953 | ) | (14,886) | ) | (25336 | ) | ||||
| 其他專案(減值、外匯調整、外匯、損益、稅金等) | 13,483 | 30,149 | 14,767 | 31,197 | ||||||||
| 全面虧損總額 | (16,955 | ) | (37,102 | ) | (29,653 | ) | (56,533 | ) | ||||
| 持續經營的每股收益 | ||||||||||||
| 基本資訊 | $ | (0.15 | ) | $ | (0.39 | ) | $ | (0.29 | ) | $ | (0.60 | ) |
| 稀釋 | $ | (0.15 | ) | $ | (0.39 | ) | $ | (0.29 | ) | $ | (0.60 | ) |
| 3 months ended |
3 months ended |
12 months ended |
12 months ended |
|||||||||
| 31-Dec-22 | 31-Dec-21 | 31-Dec-22 | 31-Dec-21 | |||||||||
| (In thousands except per share data and percentages) | CDN | CDN | CDN | CDN | ||||||||
| Net Operating Revenue From Continuing Operations | $ | 11,777 | $ | 8,838 | $ | 38,189 | $ | 37,777 | ||||
| Cost of Goods Sold | 6,077 | 5,501 | 20,566 | 23,311 | ||||||||
| Realized fair value amounts included in inventory sold | (1,298 | ) | (501 | ) | (2,976 | ) | (886 | ) | ||||
| Unrealized gain on fair value of biological assets | 293 | 1,264 | 1,799 | 1,547 | ||||||||
| Cost of Goods Sold | 7,082 | 4,738 | 21,743 | 22,650 | ||||||||
| Gross Profit | 4,695 | 4,100 | 16,446 | 15,127 | ||||||||
| Gross Profit Margin | 40% | 46% | 43% | 40% | ||||||||
| Gross Profit before FV adjustment | 5,700 | 3,337 | 17,623 | 14,466 | ||||||||
| Gross Profit Margin before FV adjustment | 48% | 38% | 46% | 38% |
| 3個月 告一段落 |
3個月 告一段落 |
12個月 告一段落 |
12個月 告一段落 |
|||||||||
| 12月31日至22日 | 12月31日-12月21日 | 12月31日至22日 | 12月31日-12月21日 | |||||||||
| (除每股數據和百分比外，以千為單位) | CDN | CDN | CDN | CDN | ||||||||
| 持續經營的淨營業收入 | $ | 11,777 | $ | 8838 | $ | 38,189 | $ | 37,777 | ||||
| 銷貨成本 | 6,077 | 5,501 | 20,566 | 23,311 | ||||||||
| 已實現公允價值包含在已銷售存貨中的金額 | (1298 | ) | (501) | ) | (2,976 | ) | (886) | ) | ||||
| 生物資產公允價值未實現收益 | 293 | 1264 | 1,799 | 1,547 | ||||||||
| 銷貨成本 | 7082 | 4738 | 21,743 | 22,650 | ||||||||
| 毛利 | 4695 | 4100 | 16,446 | 15,127 | ||||||||
| 毛利率 | 40% | 百分之四十六 | 43% | 40% | ||||||||
| 淨資產調整前毛利 | 5700 | 3337 | 17,623 | 14,466 | ||||||||
| 淨資產調整前毛利率 | 48% | 百分之三十八 | 百分之四十六 | 百分之三十八 |
| 3 months ended |
3 months ended |
12 months ended |
12 months ended |
|||||||||
| 31-Dec-22 | 31-Dec-21 | 31-Dec-22 | 31-Dec-21 | |||||||||
| (In thousands except per share data and percentages) | CDN | CDN | CDN | CDN | ||||||||
| Total Comprehensive Loss | $ | (16,955 | ) | $ | (37,102 | ) | $ | (29,653 | ) | $ | (56,533 | ) |
| EBITDA (Non-IFRS) | (1,822 | ) | (4,866 | ) | (8,710 | ) | (17,487 | ) | ||||
| Adjusted EBITDA (Non-IFRS) | (56 | ) | (2,896 | ) | (3,645 | ) | (5,626 | ) |
| 3個月 告一段落 |
3個月 告一段落 |
12個月 告一段落 |
12個月 告一段落 |
|||||||||
| 12月31日至22日 | 12月31日-12月21日 | 12月31日至22日 | 12月31日-12月21日 | |||||||||
| (除每股數據和百分比外，以千為單位) | CDN | CDN | CDN | CDN | ||||||||
| 全面虧損總額 | $ | (16,955 | ) | $ | (37,102 | ) | $ | (29,653 | ) | $ | (56,533 | ) |
| EBITDA(非國際財務報告準則) | (1,822 | ) | (4,866 | ) | (8,710 | ) | (17,487 | ) | ||||
| 調整後的EBITDA(非國際財務報告準則) | (56) | ) | (2,896 | ) | (3,645 | ) | (5626 | ) |
See the Company's management's discussion and analysis for the three and twelve months ended December 31, 2022 (the "Q4 2022 MD&A") for a detailed reconciliation of EBITDA and Adjusted EBITDA to Operating Income / (Loss). SLANG's financial statements and the Q4 2022 MD&A are available on SEDAR at , and on the Company's Investor Relations website at .
見公司管理層對截至2022年12月31日的三個月和十二個月的討論和分析(“2022年第4季度MD&A“)將EBITDA和調整後的EBITDA與營業收入/(虧損)進行詳細的核對。SLANG的財務報表和2022年第四季度的MD&A可在SEDAR上查閱，也可以在公司的投資者關係網站上查閱。
Non-IFRS Measures
非國際財務報告準則計量
EBITDA, Adjusted EBITDA, adjusted gross profit, adjusted gross margin and operational cash flow are non-IFRS financial measures that the Company uses to assess its operating performance. EBITDA is defined as net earnings (loss) before net finance costs, income tax expense (benefit) and depreciation and amortization expense. Management defines Adjusted EBITDA as EBITDA adjusted for other non-cash items such as the impact of unrealized fair values, share based compensation expense, impairments, one-time gains and losses, and one-time revenues and expenses. Management defines adjusted gross profit as gross profit before fair value adjustment of biological assets. Management defines adjusted gross margin as gross margin before fair value adjustment of biological assets. Management defines operational cash flow as cash flow of the business excluding milestone payments made in connection with the Company's acquisition of HiFi, pursuant to an Agreement and Plan of Merger dated June 25, 2021, as amended. This data is furnished to provide additional information and are non-IFRS measures and do not have any standardized meaning prescribed by IFRS. The Company uses these non-IFRS measures to provide shareholders and others with supplemental measures of its operating performance. The Company also believes that securities analysts, investors and other interested parties, frequently use these non-IFRS measures in the evaluation of companies, many of which present similar metrics when reporting their results. As other companies may calculate these non-IFRS measures differently than the Company, these metrics may not be comparable to similarly titled measures reported by other companies. We caution readers that Adjusted EBITDA should not be substituted for determining net loss as an indicator of operating results, or as a substitute for cash flows from operating and investing activities. During 2022 the Company updated its definition of Adjusted EBITDA to include the impact of fair value amounts included in inventory sold and unrealized gain on changes in fair value of biological assets. The comparative 2021 figures have been updated to conform to this current period presentation.
EBITDA、調整後的EBITDA、調整後的毛利、調整後的毛利和運營現金流是公司用來評估其經營業績的非IFRS財務指標。EBITDA被定義為扣除淨財務成本、所得稅費用(收益)以及折舊和攤銷費用之前的淨收益(虧損)。管理層將經調整EBITDA定義為經其他非現金專案調整的EBITDA，例如未實現公允價值、基於股份的薪酬支出、減值、一次性損益以及一次性收入和支出的影響。管理層將調整後的毛利定義為生物資產公允價值調整前的毛利。管理層將調整後的毛利定義為生物資產公允價值調整前的毛利。管理層將運營現金流定義為業務的現金流，不包括根據日期為2021年6月25日的協定和經修訂的合併計劃與公司收購HiFi相關的里程碑付款。這些數據是為了提供更多資訊而提供的，是非國際財務報告準則的衡量標準，沒有國際財務報告準則規定的任何標準化含義。該公司使用這些非國際財務報告準則的衡量標準，為股東和其他人提供關於其經營業績的補充衡量標準。本公司還認為，證券分析師、投資者和其他相關方經常使用這些非IFRS衡量標準對公司進行評估，其中許多公司在報告業績時提出了類似的衡量標準。由於其他公司計算這些非國際財務報告準則的計量可能與本公司不同，這些指標可能無法與其他公司報告的類似標題的計量進行比較。我們提醒讀者，調整後的EBITDA不應取代確定淨虧損作為經營業績的指標，或替代經營和投資活動的現金流。於2022年期間，本公司更新了經調整EBITDA的定義，以計入已售出存貨中的公允價值金額及未實現收益對生物資產公允價值變動的影響。2021年的比較數位已更新，以符合本期列報方式。
Conference Call Details
電話會議詳細資訊
Management plans to host an investor conference call today, April 27, 2023, at 10:00am ET to discuss the results.
管理層計劃於2023年4月27日美國東部時間今天上午10：00主持一次投資者電話會議，討論業績。
Timing: Thursday, April 27th, 2023 at 10:00 am ET Dial In: 1(888) 440-5983 (US toll-free) or 1(646) 960-0202 (international)
Conference ID: 6291438
Webcast: A live webcast can be accessed via the Company's website at or
計時：4月27日(星期四)這是，2023年東部時間上午10：00撥入：1(888)440-5983(美國免費)或1(646)960-0202(國際)
會議ID：6291438
網播：現場網路直播可通過公司網站或
About SLANG Worldwide
關於俚語世界
SLANG Worldwide Inc. is the industry leader in branded cannabis consumer packaged goods, with a diversified portfolio of five distinct brands and products distributed across the U.S. Operating in 13 legal cannabis markets nationwide, SLANG specializes in acquiring and developing market-proven regional brands, as well as launching innovative new brands to seize global market opportunities and match evolving consumer tastes. The Company has over a decade of experience operating in the nascent and highly regulated cannabis sector, and its partners enjoy the benefits of that experience, with access to the SLANG playbook for successful operations, sales and marketing. Its strong product pipeline from uniquely positioned and scalable brands like O.pen, Alchemy Naturals, Ceres, Firefly, and partnerships with brands like Greenhouse Seed Company have a proven track record of success with the brands consistently ranking among the top performers in the states where SLANG operates. Learn more at slangww.com.
Slang Worldwide Inc.是品牌大麻消費包裝產品的行業領導者，擁有五個不同品牌和產品的多元化組合，分佈在美國各地。slang在全國13個合法的大麻市場運營，專門收購和開發經過市場驗證的地區性品牌，並推出創新的新品牌，以抓住全球市場機遇，滿足不斷變化的消費者口味。該公司在新生的嚴格監管的大麻行業擁有十多年的運營經驗，其合作夥伴享受著這種經驗的好處，可以獲得成功運營、銷售和營銷的俚語劇本。其強大的產品線來自獨特的定位和可擴展的品牌，如O.Pen、AlChemy Naturals、Ceres、Firefly，以及與溫室種子公司等品牌的合作夥伴關係已被證明是成功的記錄，這些品牌在俚語運營的州一直名列前茅。欲瞭解更多資訊，請訪問slangww.com。
Forward-Looking Statements
前瞻性陳述
This news release contains statements that constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur.
本新聞稿包含構成“前瞻性陳述”的陳述。此類前瞻性陳述涉及已知和未知的風險、不確定因素和其他因素，這些風險、不確定性和其他因素可能導致該行業的實際結果、業績或成就或發展與此類前瞻性陳述明示或暗示的預期結果、業績或成就大不相同。前瞻性陳述是指不是歷史事實的陳述，一般但並非總是以“預期”、“計劃”、“預期”、“相信”、“打算”、“估計”、“專案”、“可能”和類似的表述，或事件或條件“將”、“將”、“可能”、“可能”或“應該”發生。
Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management of SLANG at this time, are inherently subject to significant business, economic and competitive risks, uncertainties and contingencies that could cause actual results to differ materially from those expressed or implied in such statements. Investors are cautioned not to put undue reliance on forward-looking statements. Applicable risks and uncertainties include, but are not limited to regulatory risks, risks related to the COVID-19 global pandemic, changes in laws, resolutions and guidelines, market risks, concentration risks, operating history, competition, the risks associated with international and foreign operations and the other risks identified under the headings "Risk Factors" in the Q3 2022 MD&A and other disclosure documents available on the Company's profile on SEDAR at . SLANG is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
前瞻性陳述必須基於一些估計和假設，雖然目前俚語管理層認為這些估計和假設是合理的，但這些估計和假設本身就會受到重大商業、經濟和競爭風險、不確定性和意外事件的影響，這些風險和不確定性可能導致實際結果與此類陳述中明示或暗示的結果大相徑庭。告誡投資者不要過度依賴前瞻性陳述。適用的風險和不確定性包括但不限於監管風險、與新冠肺炎全球大流行相關的風險、法律、決議和指導方針的變化、市場風險、集中度風險、運營歷史、競爭、與國際和外國業務相關的風險以及2022年第三季度MD&A和公司簡介中“風險因素”項下確定的其他風險以及公司簡介中提供的其他披露檔案。除適用法律明確要求外，slang沒有任何義務更新或修改任何前瞻性資訊，無論是由於新資訊、未來事件還是其他原因，並明確表示不承擔任何意圖或義務。
Financial Outlook
財務展望
This news release contains a financial outlook within the meaning of applicable Canadian securities laws. The financial outlook has been prepared by management of the Company to provide an outlook for the Company's operational cash flow for the three months ended March 31, 2023 and may not be appropriate for any other purpose. The financial outlook has been prepared based on a number of assumptions including the assumptions discussed under the heading "Forward-Looking Statements". The actual results of the Company's operations for any period will likely vary from the amounts set forth in these projections and such variations may be material. The Company and its management believe that the financial outlook has been prepared on a reasonable basis. However, because this information is highly subjective and subject to numerous risks, including the risks discussed under the heading "Forward-Looking Statements", it should not be relied on as necessarily indicative of future results.
本新聞稿包含適用於加拿大證券法的財務展望。財務展望由本公司管理層編制，旨在提供本公司截至2023年3月31日止三個月的營運現金流展望，可能不適合作任何其他用途。財務展望是根據若干假設編制的，其中包括在“前瞻性陳述”標題下討論的假設。公司在任何時期的實際經營結果都可能與這些預測中規定的數額不同，這種變化可能是重大的。本公司及其管理層相信，財務展望是在合理的基礎上編制的。但是，由於這一資訊主觀性很強，存在許多風險，包括在“前瞻性陳述”標題下討論的風險，因此不應將其視為對未來成果的必然預測。
Third Party Information
第三方資訊
This press release includes market and industry data that has been obtained from third party sources, including industry publications. The Company believes that the industry data is accurate and that its estimates and assumptions are reasonable, but there is no assurance as to the accuracy or completeness of this data. Third party sources generally state that the information contained therein has been obtained from sources believed to be reliable, but there is no assurance as to the accuracy or completeness of included information. Although the data is believed to be reliable, the Company has not independently verified any of the data from third party sources referred to in this press release or ascertained the underlying economic assumptions relied upon by such sources.
本新聞稿包括從包括行業出版物在內的第三方來源獲得的市場和行業數據。本公司相信行業數據是準確的，其估計和假設是合理的，但不能保證這些數據的準確性或完整性。第三方消息來源一般聲明，其中包含的資訊是從被認為可靠的來源獲得的，但不能保證所包括資訊的準確性或完整性。儘管這些數據被認為是可靠的，但本公司尚未獨立核實本新聞稿中提及的任何第三方來源的數據，也沒有確定這些來源所依賴的基本經濟假設。
Company Contact
Mikel Rutherford, CFO
833-752-6499
公司聯繫人
首席財務官米克爾·盧瑟福
833-752-6499
Media and Investor Inquiries
Investors@SLANGww.com
媒體和投資者問詢
郵箱：Investors@SLANGww.com
KCSA Strategic Communications
Phil Carlson
SLANG@kcsa.com
KCSA戰略傳播
菲爾·卡爾森
郵箱：slang@kcsa.com
1 See "Non-IFRS Measures".
2 Preliminary and unaudited financial results are subject to customary financial statement procedures by the Company and its auditors. Actual results could be affected by subsequent events or determinations. While the Company believes there is a reasonable basis for these preliminary financial results, the results involve known and unknown risks and uncertainties that may cause actual results to differ materially. These preliminary fiscal results represent forward-looking information. See "Forward-Looking Statements" and "Financial Outlook".
3 According to BDSA data.
1見“非國際財務報告準則計量”。
2.初步及未經審計的財務結果須遵守本公司及其核數師的慣常財務報表程式。實際結果可能會受到後續事件或決定的影響。雖然公司認為這些初步財務結果有合理的基礎，但這些結果涉及已知和未知的風險和不確定因素，這些風險和不確定因素可能會導致實際結果大不相同。這些初步財務結果代表前瞻性資訊。見“前瞻性陳述”和“財務展望”。
3.根據BDSA的數據。
To view the source version of this press release, please visit
要查看本新聞稿的源版本，請訪問
譯文內容由第三人軟體翻譯。